Processing

Please wait...

Settings

Settings

Goto Application

1. WO2007086493 - MEDICINE FOR TRANSNASAL ADMINISTRATION

Publication Number WO/2007/086493
Publication Date 02.08.2007
International Application No. PCT/JP2007/051241
International Filing Date 26.01.2007
IPC
A61K 45/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
A61K 9/08 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
A61K 9/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
A61K 9/107 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
107Emulsions
A61K 9/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
12Aerosols; Foams
A61K 9/14 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
CPC
A61K 31/165
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
A61K 9/0043
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0043Nose
A61P 25/24
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
24Antidepressants
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applicants
  • 旭化成ファーマ株式会社 ASAHI KASEI PHARMA CORPORATION [JP]/[JP] (AllExceptUS)
  • 夏目 秀視 NATSUME, Hideshi [JP]/[JP] (UsOnly)
Inventors
  • 夏目 秀視 NATSUME, Hideshi
Agents
  • 石井 良夫 ISHII, Yoshio
Priority Data
2006-01944327.01.2006JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) MEDICINE FOR TRANSNASAL ADMINISTRATION
(FR) MÉDICAMENT POUR ADMINISTRATION TRANSNASALE
(JA) 経鼻投与用薬剤
Abstract
(EN)
The object is to provide an SNRI-containing preparation which has a higher absorbability compared to a conventional SNRI preparation, can produce its effect rapidly, and can be readily administered to a patient who is hard to be administered via an oral route. Disclosed is an SNRI-containing preparation for transmucosal administration or transdermal administration.
(FR)
L'invention concerne une préparation contenant un SNRI qui possède une plus haute absorbabilité qu'une préparation conventionnelle de SNRI, qui peut produire son effet rapidement, et qui peut être administrée aisément à un patient pour qui une administration par voie orale est difficile. L’invention concerne une préparation contenant un SNRI pour administration transmucosale ou transdermique.
(JA)
 従来知られているSNRI製剤よりも吸収性が高く、効果の発現が早く、さらには経口投与が困難な患者に投与しやすいSNRI含有製剤の提供を課題とする。  本発明は、SNRIを含有する経粘膜投与用製剤又は経皮投与用製剤を提供するものである。
Latest bibliographic data on file with the International Bureau